Approval · Notice of Compliance 10860 · 2009
AFINITOR: Notice of Compliance 10860
Issued December 14, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10860
- Date
- December 14, 2009
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent (mTOR kinase inhibitor)
Products in this notice
Medicinal ingredients
- EVEROLIMUS 5 MG per TAB
- EVEROLIMUS 10 MG per TAB